References
- Von Kalken C. K., Pinedo H. M., Giaccone G. Multidrug resistance from the clinical point of view. Eur. J. Cancer 1991; 27: 1481–1486
- Zwelling L. A., Hinds M., Chan D., Mayes J., Sie K. L., Parker E., Silberman L., Radcliff A., Beran M., Blick M. Characterization of an amsacrine-resistant line of human leukemia cells. J. Biol. Chem. 1989; 264: 16411–16420
- Owens J. K., Shewach D. S., Ullman B., Mitchell B. S. Resistance to 1–beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the de-oxycytidine kinase gene. Cancer Res. 1992; 52: 2389–2393
- Antonsson B. E., Avramis V. I., Nyce J., Holcenberg J. S. Effect of 5–azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/O and CCRF/CEM/ dCK-1. Cancer Res. 1987; 47: 3672–3678
- Fridland A., Verhoef V. Mechanism for Ara-CTP catabolism in human leukemic cells and effect of deaminase inhibitors on this process. Semin. Oncol. 1987; 14: 262–268
- Rosman M., Lee M. H., Creasey W. A., Sartorelli A. C. Mechanisms of resistance to 6–Thiopurines in human leukemia. Cancer Res. 1974; 34: 1952–1956
- Sobrero A. F., Bertino J. R. Clinical aspects of drug resistance. Cancer Surveys 1986; 5: 93–107
- Kalman T. J. Polyglutamylation of folates and anti-folates as a target of chemotherapy. Pharmacology and Therapeutics. Suppl. 1990, Molecular Aspects of Chemotherapy, E. Borowski, D. Sugar. Plenum Press, New York 1990; 139–297
- Galivan J., Johnson T., Rhee M., McGuire J., Priest D., Vasevan V. The role of folylpolyglutamate syn-thetase and γ-glutamyl hydrolase in altering cellular foly- and antifolylpolyglutarnates. Adv. Enzyme Regul. 1987; 26: 147–155
- Lin J. T., Tong W. P., Trippett T. M., Niedzwiecki D., Tao Y., Tan C., Steinherz P., Schweitzer B. I., Bertino J. R. Basis for natural resistance to methotrexate in human acute nonlymphoblastic leukemia. Leukemia Res. 1991; 15: 1191–1196
- Göker E., Lin J. T., Trippett T. M., Elisseyeff Y., Tong W., Niedzwiecki D., Tan C., Steinherz P., Schweitzer B. I., Bertino J. R. Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults as compared to children with this disease. Leukemia 1993; 7: 100–1004
- Lenz H. J., Schnieders B., Danenberg K., Goker E., Shane B., Bertino J. R., Danenberg P. V. A polymerase chain reaction (PCR) assay for folylpolyglutamate synthetase (FPGS) gene expression: Marked variation in human leukemia blast samples. Proc. Am. Assoc. Cancer Res. 1993; 34: 504
- Trippett T., Schelemmer S., Elisseyeff Y., Goker E., Wachter M., Steinherz P., Tan C., Berman E., Wright J., Rosowsky A., Schweitzer B., Bertino J. R. Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia. Blood 1992; 80: 1158–1162
- Dalton W. S., Mieler T. P. Multi drug resistance. Principles of Practice of Oncology: PPO updates 1991; 5: 1–13
- Arceci R. J. Clinical significance of p-glycoprotein in Multi drug Resistant Malignancies. Blood 1993; 81: 2215–2222
- Scotto K. W., Prochaska H. P. Collateral sensitivity of multidrug-resistant cells to a new family of compounds. Proc. Am. Assoc. Cancer Res. 1993; 34: 314
- Schlaifer D., Cooper M. R., Attal M., Saitor H. O., Tre-Pel J. B., Laurent G., Myers C. E. Myeloper-oxidase: an enzyme involved in intrinsic vincristine resistance in human myeloblastic leukemia. Blood 1993; 81: 482–489